By: Brooke Mccormick, Kirk Campbell
Kirk Campbell, MD, sees sparsentan as the beginning of a new treatment era for FSGS, a condition that has lacked approved therapies until now.
Brooke Mccormick is an associate editor at The American Journal of Managed Care® (AJMC®). She specializes in producing content related to various disease states, with a focus on medicine and healthcare, including topics such as oncology, public health, and digital health. Brooke's work has been featured in notable publications like Patient Care, Medical Economics, and Dermatology Times.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston


Not enough data
Brooke McCormick's articles predominantly cover healthcare and pharmaceutical topics, with a focus on medical research, treatments, disease management, and patient satisfaction. Her content heavily features cited data and expert commentary.
Given this focus, outreach to Brooke should offer access to professionals in the healthcare industry who can provide expert analysis or insights into recent studies or developments in medical research and treatment. Additionally, pitches could include data-driven stories that align with her coverage of scientific themes.
While she doesn't have a specific geographic focus indicated, it is important to note that her work covers global health-related issues without being tied to any particular region.
This information evolves through artificial intelligence and human feedback. Improve this profile .